STK11 and metabolic dysfunction-associated steatotic liver disease: Previous studies revealed that miR-122 knockdown in diet-induced NAFLD mouse model could inhibit hepatic lipogenesis via liver kinase B1 (LKB1)/AMPK signaling pathway by targeting Sirt1 (81).